Sheffield Teaching Hospitals Nhs Foundation Trust

An electronic trial tracker tool has streamlined stroke patient screening for research studies, reducing screening time by over 80% and providing accurate audit trails, with potential for wider application across clinical and research areas.

A new nuclear medicine and molecular radiotherapy suite at Weston Park Cancer Centre in Sheffield aims to improve cancer treatment efficacy and reduce side effects through sophisticated imaging and targeted therapies. The facility, opened in March 2024, addresses unmet patient needs and supports ongoing research, with a focus on neuroendocrine tumours. It emphasizes multidisciplinary safety and patient-centered care, integrating scanning facilities to optimize treatment delivery and personalization.

Sheffield Teaching Hospitals NHS Foundation Trust launches a 'matchmaking' service offering bowel cancer patients personalised 'vaccines' from their DNA mutations, aiming to prevent cancer recurrence. The Cancer Vaccine Launch Pad plans to recruit thousands across England for immunotherapy trials, initially focusing on colorectal cancer patients with surgically removed tumours and detectable ctDNA.